Navigation Links
GenScript Announces Collaboration with AMDeC: Seeks to Decrease Biological Research Costs at NYC Area Institutions
Date:12/11/2012

PISCATAWAY, N.J., Dec. 11, 2012 /PRNewswire/ -- GenScript has cemented an alliance with AMDeC, LLC, becoming a member of AMDeC's Vendor Partnership Program. The program unites academic investigators with commercial entities by providing discounted vendor pricing to consortium members, which includes NYC area research institutions, like NYU Langone Medical Center and Weill Cornell Medical College.

GenScript is offering AMDeC members DNA sequencing services at deeply discounted prices. The services feature an easy, flexible sample submission and short turnaround times. But financial incentives aren't the only motivation for this collaboration. DNA sequencing has been a catalyst for biological research since the 1970s. Access to fast, affordable sequencing has enabled researchers to sequence the first human genome, and study a variety of gene functions. Hence, the value of sequencing services to the research community has increased, as service turnaround times and prices have decreased. The GenScript-AMDeC collaboration provides scientists with rapid, economical, high-quality sequencing services, which will help accelerate research in the NYC area.

That's just the tip of the iceberg for GenScript's CEO, Frank Zhang, Ph.D., who anticipates that through this collaboration, GenScript will eventually offer its complete arsenal of one-stop custom services, including gene and peptide synthesis, protein expression and purification, antibody production, and cell line development. Access to these premier services would have the same catalytic effect as DNA sequencing has had over the years, since outsourcing these tasks expedites academic laboratory research.

"By working with AMDeC, we hope to establish services [at] every single university in the USA," said Zhang. "Our vision is to make the research easy by providing custom reagents to scientists…[so that] the productivity in academic research labs will be improved."

Both GenScript and AMDeC are committed to accelerating discoveries in biological research. Thus, it's no coincidence that the potential for advancements in science and technology through this alliance is in parallel with AMDeC's assertion as "A Catalyst for Breakthroughs" and GenScript's core motto, "Transforming Biology Research".

*Read more about the GenScript-AMDeC collaboration in the November 2012 issue of Nature Medicine.

About GenScript

Founded in 2002, GenScript is a leading biology CRO offering customized services to aid biological research, and drug discovery/development. GenScript is headquartered in Piscataway, NJ, with subsidiaries in Europe, Japan, and China.


'/>"/>
SOURCE GenScript USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenScript to Synthesize Yeast Genome with Johns Hopkins Scientists
2. GenScript Honored with the 2012 CRO Leadership Award
3. GenScript Rush Gene Synthesis - Driving Molecular Biology Research Faster
4. Sequenom Announces Leadership Appointments
5. Rusty Cage Announces Rusterizer's 30% New Year Special Discount
6. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
7. Verenium Announces $22.5 Million, Five-Year Secured Financing
8. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
9. ISPE Announces 2012 Award Winners at Global Annual Meeting
10. Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
11. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 23, 2017 , ... Federal funding for basic and ... enabler of life-saving medical and other vital technologies — deserves continued support, say leaders ... in the scientific community today in responding to the President’s budget request for Fiscal ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... unlimited source of human cardiovascular cells for research and the development of ... it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due to varying ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... applications, has announced a facility expansion to accommodate its rapid growth. , The ... new workspace and renovation of the existing areas. The expansion includes, a state-of-the-art ...
(Date:5/22/2017)... Boston, MA (PRWEB) , ... May 22, 2017 , ... ... evidence, has expanded to the East Coast. It has opened an office in downtown ... innovative therapies are finding it increasingly more important to generate evidence on the value ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
Breaking Biology News(10 mins):